Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aerie Pharmaceuticals (NQ: AERI )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Nov 18, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Aerie Pharmaceuticals

< Previous 1 2 3 4 5 Next >
Aerie Pharmaceuticals Announces Presentation at the Ophthalmology Innovation Summit Retina Innovation Showcase
From Aerie Pharmaceuticals, Inc.
Via Business Wire
Aerie Pharmaceuticals Announces Presentation at the 39th Annual Scientific Meeting of the American Society of Retina Specialists
From Aerie Pharmaceuticals, Inc.
Via Business Wire
Aerie Pharmaceuticals to Participate in the Cantor Global Healthcare Conference
From Aerie Pharmaceuticals, Inc.
Via Business Wire
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Cerevel Therapeutics... 
Via Benzinga
Exposures COVID-19
Aerie Pharmaceuticals, Inc. Announces the Appointment of Interim Executive Chair and Departure of Chairman and CEO
From Aerie Pharmaceuticals, Inc.
Via Business Wire
Aerie Pharmaceuticals Announces Appointment of Erik Pacyniak, Ph.D., D.A.B.T., as Director, Toxicology and Drug Disposition
From Aerie Pharmaceuticals, Inc.
Via Business Wire
56 Biggest Movers From Yesterday
Check out these big penny stock gainers and losers Losers Vera Therapeutics, Inc. (NASDAQ: VERA) shares tumbled 26.5% to settle at $22.48. MacroGenics, Inc. (NASDAQ... 
Via Benzinga
Mid-Afternoon Market Update: Dow Falls 70 Points; Aerie Pharmaceuticals Shares Plunge
Toward the end of trading Thursday, the Dow traded down 0.20% to 34,745 while the NASDAQ fell 0.03% to 15,157.61. The S&P also fell, dropping 0.21% to 4,471.34. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Leap Therapeutics (NASDAQ:LPTX) stock moved upwards by 27.72% to $2.46 during Thursday's regular session. As of 12:30 EST, this security is trading at a volume... 
Via Benzinga
Mid-Day Market Update: Gold Drops Over 2%; Leap Therapeutics Shares Jump
Midway through trading Thursday, the Dow traded down 0.74% to 34,557.75 while the NASDAQ fell 0.67% to 15,060.25. The S&P also fell, dropping 0.79% to 4,445.34. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
38 Stocks Moving In Thursday's Mid-Day Session
Gainers IronNet Cybersecurity, Inc. (NASDAQ: IRNT) shares jumped 30.4% to $41.90 amid increased retail investor interest in the stock on social media. Dutch Bros Inc. (NYSE: BROS... 
Via Benzinga
Why The Future Is Cloudy For This Aerie Pharmaceuticals Drug As Shares Plummet
A study in eye-disease treatment missed its mark, leading this biotech stock to dive. 
Via Investor's Business Daily
Mid-Morning Market Update: Markets Down; US Retail Sales Unexpectedly Increase in August
Following the market opening Thursday, the Dow traded down 0.45% to 34,657.69 while the NASDAQ fell 0.66% to 15,061.97. The S&P also fell, dropping 0.62% to 4,453.04. The U.S... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Leap Therapeutics (NASDAQ:LPTX) stock rose 32.64% to $2.56 during Thursday's pre-market session. The company's market cap stands at $152.7 million. Phio... 
Via Benzinga
20 Stocks Moving in Thursday's Pre-Market Session
Gainers IronNet Cybersecurity, Inc. (NASDAQ: IRNT) rose 59.7% to $51.30 in pre-market trading. IronNet Cybersecurity emerged as the most-discussed stock on Reddit’s r/... 
Via Benzinga
The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Alcon Inc. (NYSE: ALC)... 
Via Benzinga
Aerie Pharma Reports Mixed Bag On Phase 2 Dry Eye Trial
Aerie Pharmaceuticals Inc (NASDAQ: AERI) announced topline results of its Phase 2b COMET-1 study evaluating AR-15512 (TRPM8 Agonist) ophthalmic solution for dry... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Larimar Therapeutics (NASDAQ: 
Via Benzinga
Aerie Pharmaceuticals Announces Novel Dry Eye Product Candidate AR-15512 (TRPM8 Agonist) Ophthalmic Solution Achieved Statistical Significance Over Multiple Symptoms and Signs in Successful Phase 2b Clinical Study for the Treatment of Dry Eye Disease
From Aerie Pharmaceuticals
Via Business Wire
Aerie Pharmaceuticals Announces Appointment of Carolyn McAuliffe, Senior Director, Communications
From Aerie Pharmaceuticals, Inc.
Via Business Wire
Aerie Pharmaceuticals to Participate in Upcoming Investor Conferences
From Aerie Pharmaceuticals, Inc.
Via Business Wire
Aerie Pharmaceuticals Announces Appointment of Michael Bradley, Senior Director, Manufacturing
From Aerie Pharmaceuticals, Inc.
Via Business Wire
Looking into Aerie Pharmaceuticals's Return on Capital Employed
After pulling data from Benzinga Pro it seems like during Q2, Aerie Pharmaceuticals (NASDAQ:AERI) posted sales of $27.18 million. Earnings were up 7.94%, but Aerie Pharmaceuticals... 
Via Benzinga
Aerie Pharmaceuticals to Participate in the H.C. Wainwright Ophthalmology Conference
From Aerie Pharmaceuticals, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers CohBar (NASDAQ:CWBR) shares incr... 
Via Benzinga
Aerie Pharmaceuticals, inc (AERI) Q2 2021 Earnings Call Transcript
AERI earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Aerie Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update
From Aerie Pharmaceuticals, Inc.
Via Business Wire
Aerie Pharmaceuticals to Announce Second Quarter 2021 Financial Results and Host Conference Call on Wednesday, August 4, 2021
From Aerie Pharmaceuticals, Inc.
Via Business Wire
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results.... 
Via Benzinga
Exposures Product Safety
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.